GABA sustained release
Selected indexed studies
- The Glutamate/GABA-Glutamine Cycle: Insights, Updates, and Advances. (J Neurochem, 2025) [PMID:40066661]
- Antiepileptic drug mechanisms of action. (Epilepsia, 1995) [PMID:8784210]
- Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. (Annu Rev Pharmacol Toxicol, 2009) [PMID:18834313]
_Worker-drafted node — pending editorial review._
Connections
GABA sustained release helps
Sources
- The Glutamate/GABA-Glutamine Cycle: Insights, Updates, and Advances. (2025) pubmed
- Antiepileptic drug mechanisms of action. (1995) pubmed
- Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. (2009) pubmed
- Colorectal cancer cells hijack a brain-gut polysynaptic circuit from the lateral septum to enteric neurons to sustain tumor growth. (2025) pubmed
- Substrate sustained release-based high efficacy biosynthesis of GABA by Lactobacillus brevis NCL912. (2018) pubmed
- A sustained-release gel alleviates neuropathic pain in SNI mice by reversing Glu/GABA imbalance and chloride efflux disorders. (2025) pubmed
- Phasic/tonic glial GABA differentially transduce for olfactory adaptation and neuronal aging. (2024) pubmed
- Synaptic GABA release prevents GABA transporter type-1 reversal during excessive network activity. (2015) pubmed
- A phase 4 randomized active-controlled clinical study to compare the efficacy and safety of sustained-release pregabalin with immediate-release pregabalin in type 2 diabetic patients with peripheral neuropathic pain. (2024) pubmed
- Effects of sustained GABA releasing implants on pancreatic islets in mice. (2021) pubmed